RegisterLogin

GBR-12909

CAT: 0026-B3043-5Size: 5 mgDry Ice: NoHazardous: No
CAT#:0026-B3043-5Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
GBR-12909 is a potent and selective inhibitor of dopamine uptake (Ki = 1 nM). It inhibits dopamine uptake in tissue slices obtained from rat neostriatum at nanomolar concentrations. GBR-12909 (10 mg/kg IP) produces a dose-dependent decrease in the binding of cocaine to the dopamine transporter in rats. It antagonizes the ability of cocaine to elevate extracellular dopamine. It is also a potent blocker of cardiac hERG, sodium and calcium channels and shows cardiac antiarrhythmic properties. It is a potent ligand for sigma receptor. Regulators of sigma receptors are suggested to show activity against COVID-19, based on viral assay screens
Shipping Conditions
RT
Storage Conditions
-20ºC
Shelf Life
36 months

Related Products

CatalogName
B1998-50GBR-12935
B1998-10GBR-12935

Alternative Products

CatalogName
sc-200398AGBR-12909
TRC-G268005-10MGGBR-12909 Dihydrochloride
217380-01GBR 12909 Dihydrochloride
abx282345-01GBR-12909 2HCl
MBS386566-01Vanoxerine 2HCl (GBR-12909)
A10725-5Vanoxerine 2HCl (GBR-12909) 5mg
OOMC00020-50MGOOMC00020-50MG - GBR-12909 2HCl
OOMC00020-10MGOOMC00020-10MG - GBR-12909 2HCl
451111-01GBR-12909 Dihydrochloride discontinued. See 217380
TBI1458-50MGGBR-12909 2HCl, Dopamine reuptake inhibitor

Popular Products